Table 1.
Baseline patient characteristics and comorbidities.
| Characteristics | N = 137 |
|---|---|
| Age, y | 60.78 ± 14.46 |
| Body mass index | 37.38 ± 10.28 |
| Female sex | 76 (55.47) |
| Male sex | 61 (44.53) |
| Hypertension | 98 (71.5) |
| Hyperlipidemia | 62 (45.3) |
| Diabetes | 41 (29.9) |
| Coronary artery disease | 19 (13.9) |
| Peripheral arterial disease | 7 (5.1) |
| Congestive heart failure | 15 (10.9) |
| Chronic obstructive pulmonary disease | 10 (7.3) |
| Asthma | 13 (9.5) |
| Tobacco use | 24 (17.5) |
| COVID-19 positive | 4 (2.9) |
| Immobility | 9 (6.6) |
| Connective tissue disorder | 0 (0) |
| History of malignancy | 26 (19.0) |
| Exogenous hormone use | 26 (19) |
| Non-PE procedure <30 days | 13 (9.5) |
| Hospitalization <30 days | 26 (19.0) |
| Massive pulmonary embolism on admission | 34 (24.8) |
| PESI score | 79 (65-98.5) |
Categorical data are described as n (%). Continuous data are described as mean ± SD or median (IQR).
PESI, pulmonary embolism severity index.